PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues

Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly therapeutic effect on PSMA-positive tumor tissue, t...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Seiji Hoshi, Kei Yaginuma, Satoru Meguro, Akifumi Onagi, Kanako Matsuoka, Junya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Soichiro Ogawa, Motohide Uemura, Yoshiyuki Kojima
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Subjects:	theranostics PSMA prostate cancer molecular imaging radioligand therapy
Online Access:	https://www.mdpi.com/1718-7729/30/8/529